1. Home
  2. FGEN vs CTRM Comparison

FGEN vs CTRM Comparison

Compare FGEN & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • CTRM
  • Stock Information
  • Founded
  • FGEN 1993
  • CTRM 2016
  • Country
  • FGEN United States
  • CTRM Cyprus
  • Employees
  • FGEN N/A
  • CTRM N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • CTRM Marine Transportation
  • Sector
  • FGEN Health Care
  • CTRM Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • CTRM Nasdaq
  • Market Cap
  • FGEN 34.5M
  • CTRM 34.7M
  • IPO Year
  • FGEN 2014
  • CTRM N/A
  • Fundamental
  • Price
  • FGEN $0.36
  • CTRM $3.05
  • Analyst Decision
  • FGEN
  • CTRM
  • Analyst Count
  • FGEN 0
  • CTRM 0
  • Target Price
  • FGEN N/A
  • CTRM N/A
  • AVG Volume (30 Days)
  • FGEN 898.0K
  • CTRM 64.2K
  • Earning Date
  • FGEN 11-12-2024
  • CTRM 02-06-2025
  • Dividend Yield
  • FGEN N/A
  • CTRM N/A
  • EPS Growth
  • FGEN N/A
  • CTRM N/A
  • EPS
  • FGEN N/A
  • CTRM 2.39
  • Revenue
  • FGEN $180,015,000.00
  • CTRM $76,443,340.00
  • Revenue This Year
  • FGEN $19.67
  • CTRM N/A
  • Revenue Next Year
  • FGEN N/A
  • CTRM N/A
  • P/E Ratio
  • FGEN N/A
  • CTRM $1.17
  • Revenue Growth
  • FGEN 16.15
  • CTRM N/A
  • 52 Week Low
  • FGEN $0.18
  • CTRM $2.77
  • 52 Week High
  • FGEN $2.93
  • CTRM $6.50
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 45.24
  • CTRM 34.62
  • Support Level
  • FGEN $0.31
  • CTRM $2.77
  • Resistance Level
  • FGEN $0.37
  • CTRM $3.55
  • Average True Range (ATR)
  • FGEN 0.03
  • CTRM 0.17
  • MACD
  • FGEN -0.01
  • CTRM -0.04
  • Stochastic Oscillator
  • FGEN 25.66
  • CTRM 32.18

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.

Share on Social Networks: